The FDA-Approved Antiviral Raltegravir Inhibits Fascin1-Dependent Invasion of Colorectal Tumor Cells In Vitro and In Vivo
Simple Summary
Alburquerque-González, B.; Bernabé-García, Á.; Bernabé-García, M.; Ruiz-Sanz, J.; López-Calderón, F.F.; Gonnelli, L.; Banci, L.; Peña-García, J.; Luque, I.; Nicolás, F.J.; Cayuela-Fuentes, M.L.; Luchinat, E.; Pérez-Sánchez, H.; Montoro-García, S.; Conesa-Zamora, P. The FDA-Approved Antiviral Raltegravir Inhibits Fascin1-Dependent Invasion of Colorectal Tumor Cells In Vitro and In Vivo. Cancers 2021, 13, 861. https://doi.org/10.3390/cancers13040861
Alburquerque-González B, Bernabé-García Á, Bernabé-García M, Ruiz-Sanz J, López-Calderón FF, Gonnelli L, Banci L, Peña-García J, Luque I, Nicolás FJ, Cayuela-Fuentes ML, Luchinat E, Pérez-Sánchez H, Montoro-García S, Conesa-Zamora P. The FDA-Approved Antiviral Raltegravir Inhibits Fascin1-Dependent Invasion of Colorectal Tumor Cells In Vitro and In Vivo. Cancers. 2021; 13(4):861. https://doi.org/10.3390/cancers13040861
Chicago/Turabian StyleAlburquerque-González, Begoña, Ángel Bernabé-García, Manuel Bernabé-García, Javier Ruiz-Sanz, Fernando F. López-Calderón, Leonardo Gonnelli, Lucia Banci, Jorge Peña-García, Irene Luque, Francisco J. Nicolás, María L. Cayuela-Fuentes, Enrico Luchinat, Horacio Pérez-Sánchez, Silvia Montoro-García, and Pablo Conesa-Zamora. 2021. "The FDA-Approved Antiviral Raltegravir Inhibits Fascin1-Dependent Invasion of Colorectal Tumor Cells In Vitro and In Vivo" Cancers 13, no. 4: 861. https://doi.org/10.3390/cancers13040861